Offer - Urjas Oil for just ₹ 1
Pamorelin LA 22.5 Injection, a prescription drug, is manufactured in various forms such as Injection. It is primarily used for the treatment of Prostate Cancer. Other than this, Pamorelin LA 22.5 Injection has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Pamorelin LA 22.5 Injection. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Pamorelin LA 22.5 Injection also has some side effects, the most common being Excessive sweating, Paresthesia. Apart from the aforementioned side effects, Pamorelin LA 22.5 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Pamorelin LA 22.5 Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Pamorelin LA 22.5 Injection's effect during pregnancy is Severe and Severe while nursing. It is important to know if Pamorelin LA 22.5 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pamorelin LA 22.5 Injection related warnings section.
The section on Pamorelin LA 22.5 Injection contraindications lists all such conditions.
Additionally, Pamorelin LA 22.5 Injection may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Pamorelin LA 22.5 Injection is considered not safe while driving, and is not addictive.
Pamorelin LA 22.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Male) |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Pamorelin LA 22.5 Injection safe for pregnant women?
Pamorelin LA has many dangerous side effects in pregnant women. If you are pregnant, do not consume Pamorelin LA without medical advice.
Is the use of Pamorelin LA 22.5 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pamorelin LA. So it is adviced to consult the doctor before using it.
What is the effect of Pamorelin LA 22.5 Injection on the Kidneys?
Pamorelin LA rarely harms the kidneys.
What is the effect of Pamorelin LA 22.5 Injection on the Liver?
Side effects of Pamorelin LA rarely affect the liver.
What is the effect of Pamorelin LA 22.5 Injection on the Heart?
Use of Pamorelin LA may be dangerous for the heart. Do not use it without doctor's advice.
If you are suffering from any of the following diseases, you should not take Pamorelin LA 22.5 Injection unless your doctor advises you to do so -
Is this Pamorelin LA 22.5 Injection habit forming or addictive?
Pamorelin LA 22.5 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Pamorelin LA 22.5 Injection. So it is best to avoid driving.
Is it safe?
Yes, but consume Pamorelin LA 22.5 Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Pamorelin LA 22.5 Injection is not used to treat mental disorders.
Interaction between Food and Pamorelin LA 22.5 Injection
Due to the absence of research, it is difficult to say how Pamorelin LA 22.5 Injection and food will interact.
Interaction between Alcohol and Pamorelin LA 22.5 Injection
Information about the interaction of Pamorelin LA 22.5 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 53
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 242-243
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trelstar® (triptorelin pamoate)
